Evidence map›Paper›PMID 34363755›Full record

ArticleCell2021

Human TBK1 deficiency leads to autoinflammation driven by TNF-induced cell death.

Justin Taft, Michael Markson, Diana Legarda, Roosheel Patel, Mark Chan, Louise Malle, Ashley Richardson, Conor Gruber, Marta Martín-Fernández, Grazia M S Mancini and 16 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 93 papers.

0numbers the graph read from it
0cells of the map it votes in
93citing papers in PubMed
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

93 citing papers in PubMed, 133 citations in OpenAlex.

  1. Article
  2. Mechanisms, regulation and clinical relevance of necroptosis.Nature reviews. Molecular cell biology · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. CD8Nature communications · 2026
    Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Monogenic disorders of the TNF signalling pathway.Nature reviews. Rheumatology · 2026
    Review
  17. AFrontiers in immunology · 2026
    Article
  18. Article
  19. Review
  20. Article

33 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 8 institutions in 5 countries.

Justin TaftCenter for Inborn Errors of Immunity, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA; Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA; Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Michael MarksonCenter for Inborn Errors of Immunity, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA; Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA; Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Diana LegardaPrecision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Roosheel PatelCenter for Inborn Errors of Immunity, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA; Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA; Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Mark ChanDepartment of Immunology, Mayo Clinic, Rochester, MN, 55905, USA.
Louise MalleCenter for Inborn Errors of Immunity, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA; Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA; Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Ashley RichardsonCenter for Inborn Errors of Immunity, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA; Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA; Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Conor GruberCenter for Inborn Errors of Immunity, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA; Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA; Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Marta Martín-FernándezCenter for Inborn Errors of Immunity, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA; Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA; Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Grazia M S ManciniDepartment of Clinical Genetics, Erasmus University Medical Center, 3015GD Rotterdam, the Netherlands.
Jan A M van LaarDepartment of Immunology, Erasmus University Medical Center, 3015GD Rotterdam, the Netherlands.
Philomine van PeltDepartment of Rheumatology, Erasmus University Medical Center, 3015GD Rotterdam, the Netherlands.
Sofija ButaCenter for Inborn Errors of Immunity, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA; Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA; Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Beatrijs H A WokkeDepartment of Neurology, Erasmus University Medical Center, 3015GD Rotterdam, the Netherlands.
Ira K D SabliDepartment of Paediatric Infectious Diseases and Virology, Imperial College London, London, UK; Centre for Paediatrics and Child Health, Faculty of Medicine, Imperial College London, London, UK.
Vanessa Sancho-ShimizuDepartment of Paediatric Infectious Diseases and Virology, Imperial College London, London, UK; Centre for Paediatrics and Child Health, Faculty of Medicine, Imperial College London, London, UK.
Pallavi Pimpale ChavanInflammatory Disease Section, National Human Genome Research Institute, Bethesda, MD, 20892, USA; Pediatric Rheumatology, SRCC Children's Hospital, Mumbai, India.
Oskar SchnappaufInflammatory Disease Section, National Human Genome Research Institute, Bethesda, MD, 20892, USA.
Raju KhubchandaniPediatric Rheumatology, SRCC Children's Hospital, Mumbai, India; Consultant Pediatrician, Jaslok and Breach Candy Hospitals, Mumbai, India.
Müşerref Kasap CüceoğluDepartment of Pediatric Rheumatology, Hacettepe University, Ankara, Turkey.
Seza ÖzenDepartment of Pediatric Rheumatology, Hacettepe University, Ankara, Turkey.
Daniel L KastnerInflammatory Disease Section, National Human Genome Research Institute, Bethesda, MD, 20892, USA.
Adrian T TingDepartment of Immunology, Mayo Clinic, Rochester, MN, 55905, USA.
Ivona AksentijevichInflammatory Disease Section, National Human Genome Research Institute, Bethesda, MD, 20892, USA.
Iris H I M HollinkDepartment of Clinical Genetics, Erasmus University Medical Center, 3015GD Rotterdam, the Netherlands.
Dusan BogunovicCenter for Inborn Errors of Immunity, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA; Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA; Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. Electronic address: dusan.bogunovic@mssm.edu.
Child Health and Development Institute · USErasmus MC · NLNational Human Genome Research Institute · USHacettepe University · TRMayo Clinic · USNIHR Imperial Biomedical Research Centre · GBBreach Candy Hospital · INIcahn School of Medicine at Mount Sinai · US

Funding

Genetics, Pathophysiology, and Treatment of Recessive Autoinflammatory DiseasesZIAHG200372 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI KASTNER, DANIEL · 2011 to 2025
$27.2M
TRAINING PROGRAM: MECHANISMS OF VIRUS-HOST INTERACTIONST32AI007647 · NIAID · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI Domenico Tortorella · 2000 to 2026
$11.5M
Regulation of TNF Receptor-mediated Cell DeathR01AI052417 · NIAID · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI TING, ADRIAN T · 2002 to 2020
$5.9M
Human ISG15 and USP18 Deficiencies Underlying Type I InterferonopathiesR01AI127372 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Dusan Bogunovic · 2017 to 2026
$4.7M
Next Generation Resolution of Antiviral Gene NetworksR01AI151029 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Dusan Bogunovic, Brad Rosenberg · 2020 to 2026
$4.2M
Inborn Errors of Immunity Leading to Autoinflammatory SyndromesR01AI148963 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BOGUNOVIC, DUSAN · 2020 to 2024
$2.5M
Host Genetic Control of ZIKV InfectionF31AI138363 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI TAFT, JUSTIN · 2019 to 2020
$91k
Medical Research Council MR/S032304/1NIAID NIH HHS F31 AI138363NIAID NIH HHS R01 AI052417NIAID NIH HHS R01 AI127372NIAID NIH HHS R01 AI148963NIAID NIH HHS R01 AI151029NIAID NIH HHS T32 AI007647
6 · The paper itself

Abstract

TANK binding kinase 1 (TBK1) regulates IFN-I, NF-κB, and TNF-induced RIPK1-dependent cell death (RCD). In mice, biallelic loss of TBK1 is embryonically lethal. We discovered four humans, ages 32, 26, 7, and 8 from three unrelated consanguineous families with homozygous loss-of-function mutations in TBK1. All four patients suffer from chronic and systemic autoinflammation, but not severe viral infections. We demonstrate that TBK1 loss results in hypomorphic but sufficient IFN-I induction via RIG-I/MDA5, while the system retains near intact IL-6 induction through NF-κB. Autoinflammation is driven by TNF-induced RCD as patient-derived fibroblasts experienced higher rates of necroptosis in vitro, and CC3 was elevated in peripheral blood ex vivo. Treatment with anti-TNF dampened the baseline circulating inflammatory profile and ameliorated the clinical condition in vivo. These findings highlight the plasticity of the IFN-I response and underscore a cardinal role for TBK1 in the regulation of RCD.

Indexed as

A549 CellsAdaptor Proteins, Signal TransducingApoptosisAutoimmunityBrainCell DeathCytokinesDeubiquitinating Enzyme CYLDFemaleHEK293 CellsHomozygoteHumansI-kappa B KinaseImmunophenotypingInflammationInterferon-gammaAdaptor Proteins, Signal TransducingCYLD protein, humanCytokinesDeubiquitinating Enzyme CYLDI-kappa B KinaseInterferon-gammaInterferon Type IMAVS protein, humanProtein Serine-Threonine KinasesReceptor-Interacting Protein Serine-Threonine KinasesReceptors, Pattern RecognitionRIPK1 protein, humanTBK1 protein, humanToll-Like Receptor 3Tumor Necrosis Factor-alphaautoinflammationIKKEinterferon type IIRF3RIPK1TBK1 deficiencyTNF alphaviral susceptibility

Identifiers

PMID34363755
PMCPMC8380741
OpenAlexW3190205340

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.